Lifeward (LFWD) Interest Expenses (2013 - 2014)
Lifeward recorded quarterly Interest Expenses of -$204000.0 in Q4 2014, down 4625.29% quarter-over-quarter from $4508.0 in Q3 2014, and up 71.82% year-over-year from -$118726.7 in Q4 2013.
Lifeward's Interest Expenses history runs 2 years deep, the most recent figure standing at -$204000.0 for Q4 2014.
- In Q4 2014, Interest Expenses rose 71.82% year-over-year to -$204000.0; the TTM figure through Sep 2015 stood at -$204000.0 (up 71.64% YoY), while the FY2021 annual figure was $907000.0, changed 0.0% from the prior year.
- Interest Expenses came in at -$204000.0 for Q4 2014 at Lifeward, down from $4508.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $4508.0 in Q3 2014 to a low of -$724000.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -204,000.00 |
| Dec 31, 2014 | -204,000.00 |
| Sep 30, 2014 | 4,508.00 |
| Sep 30, 2014 | 4,508.00 |
| Dec 31, 2013 | -724,000.00 |
| Dec 31, 2013 | -724,000.00 |
| Sep 30, 2013 | 53.00 |
| Sep 30, 2013 | 53.00 |